Publication | Closed Access

The involvement of DAMPs-mediated inflammation in cyclophosphamide-induced liver injury and the protection of liquiritigenin and liquiritin

InflammationAnti-inflammatoryAutoimmune DiseaseHepatologyDamps-mediated InflammationMedicineLiver PhysiologyImmunologyHepatitisHepatology InflammationAutoimmunityCyclophosphamide-induced Liver InjuryHepatotoxicityLiver DiseasePharmacologyDrug-induced Liver Injury